India 
Franklin Asian Equity Fund - Invest Now with Franklin Templeton India
Add to Compare 
Add to Watchlist
This fund has very high risk 
979.21 Cr AUM 
As of 30/06/2026 
41,000 Existing Investors As of 30/06/2026 12,500 investors joined last month As of 31/07/2026 As of30/06/2026 41,000 As of30/06/2026 As of31/07/2026 12,500 As of31/07/2026 As of 30/06/2026 979.21 Cr As of 30/06/2026 - Expense Ratio[#] As of 30/06/2026 1.93%
- NAV As of 07/08/2026 44.2342
- An open ended equity scheme following the Asian (excluding Japan) equity theme.
- It is suitable for investors seeking geographical diversification and exposure to Asian equities.
How does the fund work?
- The fund invests in Asian companies or sectors (excluding Japan) which have a long term growth potential across market capitalization.
- It gives investors access to a portfolio of quality companies in the Asian region that are well positioned to take advantage of the long term growth potential.
Show Transcript
For the platform transcript and captions, open the video on YouTube.
This video has a transcript option next to the fund video button.
- This fund invests in Asian companies or sectors (excluding Japan) which have a long term growth potential across market capitalization
- It gives investors access to a portfolio of quality companies in the Asian region that are well positioned to take advantage of the long term growth potential
Alternative To
Investments in Asian (excluding Japan) Companies
Suitable For
Retirement Corpus
Long Term Wealth Creation
Overseas Diversification of Assets
- Taiwan Semiconductor Manufacturing Co. Ltd. (Semiconductors & Semiconductor Equipment)
- Samsung Electronics Co Ltd (Technology Hardware & Equipment)
- SK Hynix Inc. (Semiconductors & Semiconductor Equipment)
- ICICI Bank Ltd. (Banks)
- Yageo Corp. (Technology Hardware & Equipment)
- MediaTek Inc. (Semiconductors & Semiconductor Equipment)
- Tencent Holdings Ltd. (Media & Entertainment)
- Torrent Pharmaceuticals Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)
- Oberoi Realty Ltd. (Real Estate Management & Development)
- HDFC Bank Ltd. (Banks)
Portfolio Current Allocations As of 30/06/2026
Top Holdings % of Total
Portfolio Composition
Sector Breakdown % of Equity
View Portfolio NAVs & Other Details
Fund Managers
Shyam Sundar Sriram
Sandeep Manam
Scheme Details
| Inception | 16/01/2008 |
|---|---|
| Benchmark(s) | Linked 75% MSCI Asia (Ex-Japan) Standard Index + 25% Nifty 500 Index |
| Entry Load | Nil |
| Exit Load | 1% if the units are redeemed/switched- out within one year from the date of allotment |
| AUM (Month end) | 979.21 crores |
| Minimum Investment/Multiples for Fresh Purchase (₹) | 5000/1 |
| Additional Investment/Multiples thereof (₹) | 1000/1 |
Financial Ratio
| Portfolio Turnover | 57.10% |
|---|
Managed funds by
Fund Documents
Product Label as on July 31, 2026
- Long term capital appreciation
- A fund that invests in stocks of Asian companies / sectors (excluding Japan)
The risk of the benchmark is Very High risk
Riskometer of Benchmark:75% MSCI Asia (Ex-Japan) Standard Index + 25% Nifty 500 Index
Disclaimers
IDCW - Income Distribution cum Capital Withdrawal
**The information given here is neither a complete disclosure of every material fact of Income-tax Act 1961 nor does it constitute tax or legal advice. Investors are requested to review the scheme documents carefully and obtain expert professional advice with regard to specific legal, tax and financial implications of the investment/participation in the scheme.
* All portfolio holdings are subject to change. The information stated above does not constitute an investment advice or recommendation to subscribe or transact in these securities.
** Annualized risk free rate assumed to be FIBL Overnight MIBOR
[#] Base Expense Ratio (BER) is the actual expense ratio charged as per the AUM slabs and within the BER limits prescribed in Regulation 66 of SEBI MF regulations. BER excludes brokerage and transaction costs incurred towards execution of trades and the applicable statutory levies as on that date. Brokerage and transaction costs incurred towards execution of trades and statutory levies are charged, at actuals, and is over and above the BER.
For Total Expense Ratio (TER) and break up of TER i.e., BER, brokerage and transaction costs and statutory levies, please refer to daily TER disclosures on our website www.franklintempletonindia.com. For detailed understanding of TER, please refer to the TER note on our website - https://www.franklintempletonindia.com/download/en-in/total-expense-ratio-of-schemes/49398d62-7ed8-4152-b772-68b514453013/TER-Note-for-Website_10Apr2026.pdf
Past performance may or may not be sustained in the future.
SIP returns are assuming investment made on first business day of every month and not disclosed for closed-end funds. Returns greater than 1 year period are compounded annualized. For liquid funds, the less than 1 year returns are simple annualized. Load has not been taken into consideration. Performance of dividend plan / option would be at the gross rates. Dividends are assumed to be reinvested and Bonus is adjusted. For equity oriented funds, additional benchmark chosen is Nifty 50. Given the asset allocation, hybrid fund performance are not comparable with pure equity/debt fund performance and that of Additional Benchmarks.
Past performance may or may not be sustained in future. Pursuant to payment of income distribution cum capital withdrawal (IDCW), the NAV of the scheme will fall to the extent of payout and statutory levy (if applicable)
The income distribution cum capital withdrawal (IDCW) rates could be inclusive of statutory levy, if any. The income distribution cum capital withdrawal (IDCW) received by investors will be net of statutory levy (as applicable).
The income distribution cum capital withdrawal (IDCW) payout post 1st April 2020 shall be subject to tax deducted at source i.e. TDS, as applicable.
Disclaimer :
Benchmark returns calculated based on Total Return Index Values